Paige AI

Paige develops AI-native digital pathology products for cancer diagnosis and treatment. The company has built computational pathology solutions using deep learning models trained on millions of pathology slides. Paige received FDA approval for its FullFocus product, becoming one of the first AI systems authorized for cancer diagnosis. The company partners with Memorial Sloan Kettering Cancer Center and serves pathology labs globally. Paige raised $145M in funding and focuses on improving cancer detection accuracy and pathologist workflow efficiency.